Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Kim, NJ

Andrew Kyu Hyun Kim, Paramus, NJ US

Patent application number	Description	Published
20090307006	METHOD OF COLLABORATIVE EVALUATION INFRASTRUCTURE TO ASSESS THE QUALITY OF HEALTHCARE CLNICAL DECISION ACTORS - A voting system employing individual healthcare actors is described wherein votes representing the relation between target measurements and actual measurements are aggregated and used to determine treatment of patients.	12-10-2009

Byoung-Jo J. Kim, Morganville, NJ US

Patent application number	Description	Published
20090022152	SYSTEM AND METHOD TO SUPPORT NETWORKING FUNCTIONS FOR MOBILE HOSTS THAT ACCESS MULTIPLE NETWORKS - An IP-based corporate network architecture and method for providing seamless secure mobile networking across office WLAN, home WLAN, public WLAN, and 2.5 G/3 G cellular networks for corporate wireless data users. The system includes Internet roaming clients (IRCs), a secure mobility gateway (SMG), optional secure IP access (SIA) gateways, and a virtual single account (VSA) server. The IRC is a special client tool installed on a mobile computer (laptop or PDA) equipped with a WLAN adaptor and a cellular modem. It is responsible for establishing and maintaining a mobile IPsec tunnel between the mobile computer and a corporate intranet. The SMG is a mobile IPsec gateway installed between the corporate intranet and the Internet. It works in conjunction with the IRC to maintain the mobile IPsec tunnel when the mobile computer is connected on the Internet via a home WLAN, a public WLAN, or a cellular network. The SIA gateway is a special IPsec gateway installed in the middle of the wired corporate intranet and an office WLAN. It works with the IRC to ensure data security and efficient use of corporate IP addresses when the mobile computer is connected to the office WLAN. The VSA server manages authentication credentials for every corporate user based on a virtual single account concept. The Internet Roaming system can provide secure, always-on office network connectivity for corporate users no matter where they are located using best available wireless networks.	01-22-2009
20110038439	Method of Selecting Receive Antennas for MIMO Systems - A method of performing receive antenna selection is presented. The method executes a determination operation for a set of receive antennas, determines a maximum result of the determination operation for two of the antennas, eliminates one of the two antennas from the set of antennas, and repeats the determination and elimination process until only a predetermined number of antennas remain in the set. The signals from these remaining antennas are then processed. The present invention reduces receiver complexity and cost.	02-17-2011

Byoung-Jo J. Kim, Jersey City, NJ US

Patent application number	Description	Published
20100265892	LAYER-2 IP NETWORKING METHOD AND APPARATUS FOR MOBILE HOSTS - A method and apparatus to enable IP networking for mobile hosts without requiring changes to be made to the TCP/IP stack in the operating system installed on the mobile hosts. The apparatus is an “intelligent device” that can be installed on or connected to a mobile host, and may comprise a software-only logical module, physical hardware, or a combination of both. To a mobile host, the intelligent device emulates a network interface such as an Ethernet card or a telephone modem. The intelligent device appears to an access network just like any regular IP host connected to the access network through a physical network interface device. The intelligent device handles all mobile networking functions for the mobile host, and may control multiple different physical network interface devices to enable a connection to the “best” access network available to the mobile user at his location.	10-21-2010

Byung T. Kim, Fort Lee, NJ US

Patent application number	Description	Published
20100077546	METHOD AND SYSTEM FOR HEATING A SAUNA - The present invention is directed to a system and methods for heating a room such as a spa or a sauna. In the present invention, a heating source placed upon a transportable vehicle is electrically heated in an oven and transported to the room via rail. Heat from the payload is dissipated into the room and, after the ambient temperature lowers back down, the vehicle and payload are returned to the over for subsequent re-heating.	04-01-2010

Changsoon Kim, Princeton, NJ US

Patent application number	Description	Published
20090042142	ORGANIC TRIODES WITH NOVEL GRID STRUCTURES AND METHOD OF PRODUCTION - An organic semiconductor device is provided. The device has a first electrode and a second electrode, with an organic semiconductor layer disposed between the first and second electrodes. An electrically conductive grid is disposed within the organic semiconductor layer, which has openings in which the organic semiconductor layer is present. At least one insulating layer is disposed adjacent to the electrically conductive grid, preferably such that the electrically conductive grid is completely separated from the organic semiconductor layer by the insulating layer. Methods of fabricating the device, and the electrically conductive grid in particular, are also provided. In one method, openings are formed in an electrically conductive layer with a patterned die, which is then removed. In another method, an electrically conductive layer and a first insulating layer are etched through the mask to expose portions of a first electrode. In yet another method, a patterned die is pressed into a first organic semiconductor layer to create texture in the surface of the first organic semiconductor layer, and then removed. An electrically conductive material is then deposited onto the first organic semiconductor layer from an angle to form a grid having openings as a result of the textured surface and the angular deposition. In each of the methods, insulating layers are preferably deposited or otherwise formed during the process to completely separate the electrically conductive layer from previously and subsequently deposited organic semiconductor layers.	02-12-2009

Cheoljin Kim, North Brunswick, NJ US

Patent application number	Description	Published
20120115962	CYCLODEXTRIN-MODIFIED POLYAMINES FOR DELIVERY OF THERAPEUTIC MOLECULES - The present invention is directed to drug delivery vehicles comprising one or more cyclodextrin moieties conjugated to a dendritic polyamine for the delivery of small molecule and protein therapeutic molecules and nucleic acid therapeutic molecules, and methods of making and using the delivery vehicles.	05-10-2012

Chong Kyu Kim, Fort Lee, NJ US

Patent application number	Description	Published
20100032958	Hyper-surface wind generator - An electric generator capable of generating electric power using kinetic energy of wind includes a first plurality of rotor plates, a second plurality of rotor plates, and a first plurality of blades capable of driving the first plurality of rotor plates, a second plurality of blades being formed to enable counter-rotation with respect to the first plurality of blades, wherein rotation of the first plurality of rotor plates relative to the second plurality of rotor plates induces electricity in a plurality of coils disposed on the second plurality of rotor plates, and wherein at least one of the first and second plurality of rotor plates are arranged co-axially with the shaft such that respective radii of the at least one of the first and second plurality of rotor plates are varied along the axial direction.	02-11-2010
20100038987	Motors Having a Hyperbolic Cosine Curve Shape - A motor having a hyperbolic cosine curve shaped rotor and a matching hyperbolic cosine curve shaped stator.	02-18-2010
20110187224	Durable and Wearless Rotating Conductor Assembly Based on an Internal Magnetic Field for Transmitting Voltage and Current - This invention relates to a brushless slip ring using bearing for transmitting voltage and current between rotating rotor and stator. The invention relates to attaching a magnet to the slip ring to create a more stable rotor, eliminating sparks and erosions caused by the disconnection at times to the stator by enforcing a magnetic pull to the stator wall. In addition, a cooling-filtering system with synthetic oil can provide sufficient and constant clean lubrication.	08-04-2011
20120086295	MOTORS WITH QUADRIC SURFACES - A motor having a rotor whose outer surface conforms to a non-degenerate quadric surface, and a matching stator.	04-12-2012

Chung-Sei Kim, Palisade Park, NJ US

Patent application number	Description	Published
20100227374	PROTEIN STABILIZATION BY DOMAIN INSERTION INTO A THERMOPHILIC PROTEIN - A strategy to improve protein stability by domain insertion. TEM 1 beta-lactamase (BLA) and exo-inulinase, as model target enzymes, are inserted into a hyperthermophilic maltose binding protein from	09-09-2010

David Kim, North Bergen, NJ US

Patent application number	Description	Published
20110224136	INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below.	09-15-2011
20110224137	INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).	09-15-2011

David Won-Shik Kim, Edison, NJ US

Patent application number	Description	Published
20090170861	Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors - In its many embodiments, the present invention provides -substituted pyridazinone compounds as glucan synthase inhibitors, methods of preparing such compounds, pharmaceutical including one or more of such compounds, methods of preparing pharmaceutical formulations including one or more such compounds or one or more such compounds along with other antifungal agents, and methods of treatment, prevention, inhibition, or amelioration of one or more fungal infections associated with glucan synthase using such compounds or pharmaceutical compositions.	07-02-2009

David Won-Shik Kim, North Bergen, NJ US

Patent application number	Description	Published
20110319403	BICYCLIC COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).	12-29-2011

Deok-Yang Kim, New Brunswick, NJ US

Patent application number	Description	Published
20090289526	DEVICES HAVING A TUNABLE ACOUSTIC PATH LENGTH AND METHODS FOR MAKING SAME - A tunable acoustic resonator device. The device has a piezoelectric medium as a first thin film layer and a tunable crystal medium as a second thin film layer. The tunable crystal medium has a first acoustic behavior over an operating temperature range under a condition of relatively low applied stress and a second acoustic behavior under a condition of relatively high applied stress. The acoustic behaviors are substantially different. The tunable crystal medium has a highly field-polarizable and lattice-deformable, substantially centrosymmetric structure over an operating temperature range under a condition of relatively low applied stress. The tunable crystal medium has a substantially non-centrosymmetric structure over said operating temperature range under a condition of relatively high applied stress. The dielectric permittivity of the tunable crystal medium is at least 100 at the relatively low applied stress. The tunable crystal medium is close to its ferroelectric instability but remains paraelectric throughout the operating temperature range of the device. The phase transition temperature of the tunable crystal medium from paraelectric to ferroelectric state is just below the operating temperature range.	11-26-2009
20100277034	ARRAY OF BAW RESONATORS WITH MASK CONTROLLED RESONANT FREQUENCIES - Methods that create an array of BAW resonators by patterning a mass load layer to control the resonant frequency of the resonators and resonators formed thereby, are disclosed. Patterning the surface of a mass load layer and introducing apertures with dimensions smaller than the acoustic wavelength, or dimpling the mass load layer, modifies the acoustic path length of the resonator, thereby changing the resonant frequency of the device. Patterns of variable density allow for further tuning the resonators and for individualized tuning of a resonator in an array of resonators. Patterning a reflowable material for the mass load layer, thereby providing a variable pattern density and distribution followed by elevating the temperature of the mass load layer above its melting point causes the material to liquefy and fill into the apertures to redistribute the mass load layer, thereby, upon subsequent cooling, providing resonators with a predetermined desired resonant frequency.	11-04-2010
20120079692	ARRAY OF BAW RESONATORS WITH MASK CONTROLLED RESONANT FREQUENCIES - Methods that create an array of BAW resonators by patterning a mass load layer to control the resonant frequency of the resonators and resonators formed thereby, are disclosed. Patterning the surface of a mass load layer and introducing apertures with dimensions smaller than the acoustic wavelength, or dimpling the mass load layer, modifies the acoustic path length of the resonator, thereby changing the resonant frequency of the device. Patterns of variable density allow for further tuning the resonators and for individualized tuning of a resonator in an array of resonators. Patterning a reflowable material for the mass load layer, thereby providing a variable pattern density and distribution followed by elevating the temperature of the mass load layer above its melting point causes the material to liquefy and fill into the apertures to redistribute the mass load layer, thereby, upon subsequent cooling, providing resonators with a predetermined desired resonant frequency.	04-05-2012

Doh-Suk Kim, Basking Ridge, NJ US

Patent application number	Description	Published
20090094026	METHOD OF DETERMINING AN ESTIMATED FRAME ENERGY OF A COMMUNICATION - A method of processing a communication includes determining an estimated excitation energy component of a subframe of a coded frame. A filter energy component of the subframe is also estimated. Determining an estimated energy of the subframe is based upon the estimated excitation energy component and the estimated filter energy component. This technique allows for estimating frame energy of a communication such as a voice communication without having to fully decode the communication.	04-09-2009
20100054454	Method and apparatus for the detection and suppression of echo in packet based communication networks using frame energy estimation - A method and apparatus for use in suppressing acoustic echo in a target speech signal being transmitted through a packet-based communications network uses frame energy estimation applied to the target speech signal and to a reference speech signal. The method or apparatus estimates one or more reference speech energy levels in one or more reference packets based on one or more of the speech parameters generated by the speech encoding of the reference signal; estimates a target speech energy level in a target packet based on one or more of the speech parameters generated by the speech encoding of the target signal; compares the target speech energy level to one or more reference speech energy levels; and detects an echo in the target speech signal based on the comparison of the target speech energy level to the one or more reference speech energy levels.	03-04-2010
20110235632	Method And Apparatus For Performing High-Quality Speech Communication Across Voice Over Internet Protocol (VoIP) Communications Networks - A communications terminal device and a method performed by a communications terminal device wherein packet data received from a Wireless Personal Area Network (WPAN) headset (such as, for example, a Bluetooth headset), which comprises an encoded audio signal, is directly convened by the terminal device to Internet Protocol (IP) packets which are transmitted across a Voice over Internet Protocol (VoIP) communications network, wherein speech encoding is not performed by the terminal device. Similarly, a communications terminal device and a method performed by a communications terminal device wherein IP packet data comprising an encoded audio signal is received from a VoIP communications network by the terminal device, and is directly converted by the terminal device to WPAN packets (such as, for example, Bluetooth protocol packets) which are transmitted to a WPAN headset (such as, for example, a Bluetooth headset), wherein speech decoding is not performed by the terminal device.	09-29-2011

Dooseop Kim, Westfield, NJ US

Patent application number	Description	Published
20090264405	Cetp Inhibitors - Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.	10-22-2009
20100130504	BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.	05-27-2010
20100216694	ANTIDIABETIC TRICYCLIC COMPOUNDS - Tricyclic compounds containing a cyclopropanecarboxylic acid fused to a bicyclic ring, including pharmaceutically acceptable salts, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.	08-26-2010
20100298288	CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES - Compounds having the structure of Formula I1 including pharmaceutically acceptable salts of the compounds, are potent CETP (cholesterol ester transfer protein) inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis Atherosclerosis and its clinical consequences, coronary heart disease (CHD), stroke and penpheral vascular disease, represent a truly enormous burden to the health care systems of the industrialized world In formula I, A-B is an arylamide moiety	11-25-2010
20110190308	NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS - The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.	08-04-2011

Gi Tae Kim, Morristown, NJ US

Patent application number	Description	Published
20080247314	Automatic policy change management scheme for DiffServ-enabled MPLS networks - A policy change management scheme for network resource management through dynamic policy adaptations especially suitable for DiffServ-enabled MPLS networks is presented. The scheme incorporates automated resource adaptation capabilities to assure QoS for user traffic and to promote resource utilization in DiffServ-enabled MPLS networks. A suite of resource management policies, an ordered set of methods for adjusting policies, and interfaces to a companion policy-based network management system are provided. The policies are periodically adjusted based on predictive bandwidth estimation algorithms ensuring optimal resource allocation to individual service classes and enabling adjustment of resources for handling current traffic and traffic expected for the near future. Resource allocations to individual service classes are adapted through policy changes when bandwidth utilization deviates from normal level or congestion exists in one or more service classes, allowing corrections to abnormal allocation of resources in incipient phases of congestion.	10-09-2008
20100011118	Call admission control and preemption control over a secure tactical network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion.	01-14-2010
20100036953	Systems and Methods for QoS Provisioning and Assurance for Point-to-Point SIP Sessions in DiffServ-enabled MPLS Networks - Systems and methods for efficiently provisioning and assuring Quality of Service (QoS) between user networks communicating over a DiffServ-enabled network, with QoS management transparency to SIP user agents. The system comprises user networks communicating via a core network, each user network having a source and destination SIP user agent respectively, a SIP proxy server between the source SIP user agent and destination SIP user agent, a Bandwidth Manager to provision a pipe between the source user network and the destination user network, wherein the pipe has a specified bandwidth, and a QoS Agent for accepting and/or rejecting a SIP session based on availability of bandwidth in the pipe; wherein the SIP proxy server is configured to forward an incoming SIP request to the QoS Agent. The method comprises provisioning a pipe between the SIP user agents or their respective user networks, and allowing/rejecting incoming SIP sessions based on the available bandwidth in the pipe.	02-11-2010
20110211480	Call Admission Control and Preemption Control Over a Secure Tactical Network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion.	09-01-2011

Haesun Kim, Teaneck, NJ US

Patent application number	Description	Published
20100029559	Method for achieving desired glial growth factor 2 plasma levels - The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the disease or disorder afflicting the patient. In a particular embodiment, the patient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient.	02-04-2010

Heechang Kim, Marlboro, NJ US

Patent application number	Description	Published
20080212545	Demand-driven prioritized data structure - A system and method for optimizing the efficiency of data sharing among a set of radio nodes in a radio environment is provided. The technique includes identifying a data unit and assigning it a class, identifying a connectivity type, computing a significance factor based on connectivity type and assigned class, mapping the significance factor to a priority factor, and scheduling output of the data unit based on the priority factor. A scheduler algorithm can be used for scheduling output. The class can be assigned based on which nodes of the set of radio nodes possess copies of the data unit at a given time. An arbitration process can be used to determine the priority factor. A significance factor weighting algorithm, based on how many nodes will be receiving the data and on how much a node needs the data, can be used to determine the significance factor.	09-04-2008
20100265836	Self-Correcting Adaptive Tracking System (SATS) - A system and method for self and group location and tracking based on ultra wide band ranging among members of the group is presented. The system comprises an anchored station, a plurality of nodes, each node having at least knowledge of where the node is facing and heading, knowledge of all pair wise distances among all of the plurality of nodes, and ability to exchange information among the nodes and with the anchored station via relays. The system and method find a new position estimate of the group in accordance with an adaptive search process based on constraints of the ultra wide band ranging, and the search process enables extracting directional information and adaptively stabilizing orientation of the group. In one embodiment, adaptively stabilizing the orientation of the group is performed using an orientation-correcting polygon matching process.	10-21-2010
20100302970	Demand-Driven Prioritized Data Structure - A system and method for optimizing the efficiency of data sharing among a set of radio nodes in a radio environment is provided. The technique includes identifying a data unit and assigning it a class, identifying a connectivity type, computing a significance factor based on connectivity type and assigned class, mapping the significance factor to a priority factor, and scheduling output of the data unit based on the priority factor. A scheduler algorithm can be used for scheduling output. The class can be assigned based on which nodes of the set of radio nodes possess copies of the data unit at a given time. An arbitration process can be used to determine the priority factor. A significance factor weighting algorithm, based on how many nodes will be receiving the data and on how much a node needs the data, can be used to determine the significance factor.	12-02-2010

Hong Kook Kim, Chatahm, NJ US

Patent application number	Description	Published
20120072214	Frame Erasure Concealment Technique for a Bitstream-Based Feature Extractor - A frame erasure concealment technique for a bitstream-based feature extractor in a speech recognition system particularly suited for use in a wireless communication system operates to “delete” each frame in which an erasure is declared. The deletions thus reduce the length of the observation sequence, but have been found to provide for sufficient speech recognition based on both single word and “string” tests of the deletion technique.	03-22-2012

Hong Kook Kim, Chatham, NJ US

Patent application number	Description	Published
20090326946	Frame Erasure Concealment Technique for a Bitstream-Based Feature Extractor - A frame erasure concealment technique for a bitstream-based feature extractor in a speech recognition system particularly suited for use in a wireless communication system operates to “delete” each frame in which an erasure is declared. The deletions thus reduce the length of the observation sequence, but have been found to provide for sufficient speech recognition based on both single word and “string” tests of the deletion technique.	12-31-2009

Hongkyu Kim, Old Bridge, NJ US

Patent application number	Description	Published
20090308774	Methods for Proctecting Glass - Described herein are methods for protecting glass with the use of glassine paper.	12-17-2009

Hongwook Kim, Montville, NJ US

Patent application number	Description	Published
20100093801	PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AND ITS USE - Piperidine compounds and pharmaceutically useful salts thereof, a pharmaceutical composition including an effective amount of the racemic or enantiomerically enriched piperidine compounds to treat gastrointestinal diseases, and a method of treating gastrointestinal diseases in a mammal are provided.	04-15-2010

Hong-Yong Kim, Whippany, NJ US

Patent application number	Description	Published
20090131707	CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS - Improved processes for preparing intermediates useful for preparing antibacterial N-[1-oxo2-alkyl-3-(N-hydroxyformamido)-propyl}-(carbonylamino-aryl or -heteroaryl)-azacyclo4-7alkanes or thiazacyclo4-7alkanes, which have one or more of the following features: (1) make use of a particular I3-lactam intermediate; (2) which make use of a particular resolving agents, enantiomerically pure substituted propionic acids, especially (R)-2-butyl-3-hydroxypropionic acid; (3) which avoid the use of hydrogen peroxide; and (4) which facilitate selective debenzylation reducing production of waste by-products.	05-21-2009
20100197705	Quinazolinone Derivatives Useful as Vanilloid Antagonists - There is described a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile having structural formula I(B) and to a method of preparing it.	08-05-2010

Hyeon Ju Kim, Closter, NJ US

Patent application number	Description	Published
20080297894	DISPLAY DEVICE - Disclosed is a display device including an image source unit shaped like a plate to form an image; and an image magnifying unit including a plurality of light transfer members each extended in a first direction and arrayed in a second direction transverse to the first direction, each light transfer member is shaped like a plate, of which a longitudinal direction is parallel with a surface of the image source unit and a height direction is transverse to the surface of the image source, and includes a plurality of cutting parts arrayed in the longitudinal direction and form a plurality of light guide channels. With this configuration, there is provided a display device which can reduce a problem that a joint is distinctive to a user's eye.	12-04-2008

Hyunjin Kim, Livingston, NJ US

Patent application number	Description	Published
20110224136	INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below.	09-15-2011
20110224137	INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).	09-15-2011
20110224193	INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE - The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown with this abstract.	09-15-2011

Jae Hwan Kim, Highland Park, NJ US

Patent application number	Description	Published
20120020931	THERAPEUTIC ENCAPSULATED EMBRYONIC STEM CELLS AND MESENCHYMAL STROMAL CELLS - This application discloses alginate microencapsulation-mediated differentiation of embryonic stem cells and use of the stem cell differentiation method for the development of effective treatment of various diseases and disorders. The microencapsulation of embryonic stem (ES) cells results in decreased cell aggregation and enhanced neural lineage differentiation through incorporating the soluble inducer retinoic acid (RA) into the permeable microcapsule system. This application also discloses a micro-encapsulation system for immobilizing mesenchymal stromal cells (MSCs) while sustaining the molecular communication. Thus, the invention provides the use of encapsulated mesenchymal stromal cells in the cellular transplantation therapies. Moreover, the invention provides methods for delivery of encapsulated MSCs into the central nervous system and therapies derived therefrom, such as, the treatment of spinal cord injury (SCI) and other inflammatory conditions.	01-26-2012

Jaehyong Kim, Fort Lee, NJ US

Patent application number	Description	Published
20120170145	MIRROR ASSEMBLY FOR REDUCING BLIND SPOT ASSOCIATED WITH SIDE VIEW MIRRORS FOR VEHICLES - A mirror assembly for reducing a blind spot associated with an exterior mounted side view mirror of a vehicle is provided. The mirror assembly includes a mount assembly configured for being received about an interior intersection of the A-pillar and the door panel of the vehicle. The mirror assembly also has a mirror carried by the mount assembly and positioned within a sightline defined when the operator is viewing the exterior mounted side view mirror.	07-05-2012

Jeong Min Kim, Morristown, NJ US

Patent application number	Description	Published
20110202424	RICH CONTENT CREATION, DISTRIBUTION, AND BROADCASTING SYSTEM - A system for creating rich content displayable on a webpage. The system includes content files stored on a server and an editor displayed by a client in a Rich Internet Application (‘RIA’). The editor has a region into which content objects may be inserted to create a rich content item. At least a portion of the content objects are linked to content files stored on the server. The system generates a code segment operable to generate a display on a webpage based on the rich content item that does not use the RIA. The display is substantially equivalent to the rich content item displayed in the editing region using the RIA. The code segment is configured to be search engine friendly. The system may broadcast a common Rich Content item between a Broadcaster and a viewer both of whom may edit the Rich Content item at the same time.	08-18-2011

Ji-In Kim, Princeton, NJ US

Patent application number	Description	Published
20090042964	AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS - The present invention provides a 2-amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compound of formula I	02-12-2009
20090048320	AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE - The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.	02-19-2009
20100168194	Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase - The present invention provides compounds and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.	07-01-2010

Jong Bok Kim, Plainsboro, NJ US

Patent application number	Description	Published
20110250718	LAMINATION AS A MODULAR APPROACH FOR BUILDING ORGANIC PHOTOSENSITIVE DEVICES - There is disclosed a modular lamination approach for processing organic photosensitive devices that allows the individual processing of device components, that once processed are brought together in a final step to make electrical contact. The disclosed method of preparing a laminated photosensitive device having at least one donor-acceptor heterojunction comprises: preparing a top electrode by depositing a functional material on a flexible substrate, such as an elastomer; optionally processing the functional material to obtain desired properties prior to lamination; preparing a bottom portion by depositing a second functional material over a substrate; optionally processing the second functional material to obtain desired properties prior to lamination; and coupling the top electrode to said bottom portion to form a laminated photosensitive device.	10-13-2011

Jongjin George Kim, East Windsor, NJ US

Patent application number	Description	Published
20110200319	OPTICAL IMAGE SYSTEMS - The present invention is an optical image system having at least a first camera including a first lens and at least a second sensor including a second lens. The system also includes at least one beam splitter for transmitting an incoming beam of electromagnetic radiation of at least a first band of wavelength to a focal plane array of the first camera and reflecting an incoming beam of electromagnetic radiation of at least a second band of wavelength to a focal plane array of the second camera. The first lens is positioned behind the beam splitter for focusing the beam of the first band of wavelength onto an image at the focal plane array of the first camera and the second lens is positioned behind the beam splitter for focusing the beam of the second band of wavelength onto the image at the focal plane array of the second camera.	08-18-2011

Kyoung S. Kim, North Brunswick, NJ US

Patent application number	Description	Published
20090054436	MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS - The present invention is directed to compounds having the formula	02-26-2009
20100183606	MONOCYCLIC HETEROCYCLES AS KINASE INHIBITORS - The present invention is directed to compounds having the formula	07-22-2010
20110294793	HYDROXYPHENYL SULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS - The present invention provides compound of Formula (I): or a stereoisomer, tautomer, salt or solvate thereof, wherein the variables are defined herein. The compounds of formula (I) are inhibitors of Bcl-2 family antiapoptotic proteins, compositions containing the compounds and methods of treating diseases using the compounds.	12-01-2011

Kyung Jung Kim, Little Ferry, NJ US

Patent application number	Description	Published
20100223954	Ornament With Attachable Decorative Elements - An ornament for a person comprises: an attachment body having an at least partially closed loop shape and including first and second side wall portions; a guide rail formed of an elongated member, the guide rail including a first end pivotally fixed to or extending from the first side wall portion of the attachment body in a direction inwardly to said at least partially closed loop shape of the attachment body, a second end, and a parallel rail portion extending between the first and second ends of the guide rail; and an decorative element having first and second lateral sides, and including a guide hole formed through the first and second lateral sides, the guide hole configured to insert the second end of the guide rail there-through and having a width the same as or slightly wider than the size of the parallel rail portion of the guide rail to enable a sliding movement of the decorative element along the guide rail. The second end of the guide rail is displaceable or deformable outwardly from the attachment body to enable said insertion of the decorative element through the guide hole of the decorative element, and is returnable or recoverable to an original position to prevent the inserted decorative element from missing out of the guide rail as its movement is restricted by the first and second side wall portions of the attachment body.	09-09-2010

Kyungtae Kim, West Windsor, NJ US

Patent application number	Description	Published
20090141631	VOICE ADAPTIVE GATEWAY PACING METHODS AND SYSTEMS FOR WIRELESS MULTI-HOP NETWORKS - In accordance with aspects of the present principles, the quality of voice traffic and bandwidth utilization for data communication over a wireless multi-hop network may be improved. In an implementation of the present principles, a data packet transmission rate over a wireless multi-hop network may be controlled at an interface between the multi-hop network and a wired network based on a voice packet quality measure calculated from network parameters. Voice and data traffic quality and efficiency may be further improved by reordering a packet transmission queue at the interface to avoid timeout and/or varying a packet queue length at the interface using an acknowledgement window transmitted to a data packet sender.	06-04-2009
20110218768	Sequential Sensing Scheme for Cognitive Radio Based on a Block of Received Samples - A method and system for determining whether a given electromagnetic frequency is in use includes applying a transformation to an amplitude of received samples, adjusting the transformed samples by a constant based on a minimum detection signal-to-noise ratio; combining the adjusted samples to produce a test statistic; and using a processor to make a determination regarding if the frequency is in use based on the test statistic exceeded or falling below a threshold, said test statistic being based on Ξ	09-08-2011
20120195214	MULTITAPER SPECTRUM SENSING SYSTEMS AND METHODS - Spectrum sensing methods and systems for detecting spectrum holes for use in cognitive radio secondary transmissions are disclosed. In one method, an indication of an assignment of a set of subcarriers to a primary user is received. The method further includes determining multitaper spectral estimates for at least a subset of the set of subcarriers based on the assignment of the set of subcarriers to the primary user by processing samples for the at least a subset of the set of subcarriers. In addition, a test statistic that is based on the multitaper spectral estimates is compared to a threshold to determine whether the set of subcarriers is utilized for primary transmissions to the primary user. Moreover, data signals are received on at least one of the subcarriers in the set of subcarriers if the set of subcarriers is not utilized for primary transmissions to the primary user.	08-02-2012

Mingoo Kim, Franklin Lakes, NJ US

Patent application number	Description	Published
20080313927	Arch support with a patterned surface - An arch support orthotic device comprises an upper surface facing a wearer's foot, and a lower surface facing a footwear, wherein the upper surface is formed of a deformable semi-rigid material responding flexibly to a weight of the wearer, and wherein the lower surface comprises an arch support section facing an inner sole surface of the footwear including a plurality of support structures that performs an arch supporting function, controls a deformability of the orthotic device so as to reduce loss of the arch supporting function when worn by the wearer, and prevents substantial deformation against the inner sole surface of the footwear.	12-25-2008

Paul Kim, Mahwah, NJ US

Patent application number	Description	Published
20090204995	SYSTEM AND METHOD FOR FILTERING A TELEVISION CHANNEL LIST BASED ON CHANNEL CHARACTERISTICS - A system and method for automatically managing television channel lists is disclosed. Pixel resolutions characteristics of a plurality of televisions channels are analyzed. One or more high definition television (HDTV) channels having HD pixel resolutions from the plurality of available television channels are selected. The one or more selected HDTV channels are stored in a HD channel list.	08-13-2009

Paul Suntae Kim, Mahway, NJ US

Patent application number	Description	Published
20080276277	Method and system for presenting television program guide information based on viewer usage patterns - A method and system for presenting television program guide information is provided. A program guide is obtained, and program viewing patterns of a viewer are monitored. Information from the program guide is selectively presented to the viewer based on the viewing patterns. Selectively presenting information from the program guide includes displaying a listing of channels viewed more frequently on a guide screen in descending order of viewing frequency.	11-06-2008

Paul Suntae Kim, Mahwah, NJ US

Patent application number	Description	Published
20090059000	SYSTEM AND METHOD FOR CAPTURING DEBUG INFORMATION USING A PERIPHERAL DEVICE - A system and method for capturing debug information are disclosed. In one aspect, a method comprises connecting a portable test device having a memory and no processor to a television, the test device having stored therein a debug program configured to be executed by a control unit of the television to capture debug information from the television and store the captured debug information on the test device.	03-05-2009
20100020238	METHOD AND SYSTEM FOR PICTURE-BASED USER INTERFACE FOR ADJUSTING PICTURE DISPLAY PARAMETER SETTINGS OF A DISPLAY DEVICE - A method and system for adjusting picture display settings of a display device is provided. One embodiment involves simultaneously displaying multiple pictures of the same visual content on the display device, wherein the picture setting and one or more sample pictures each at a different picture setting relative to the reference picture. Then user selection of a picture among the multiple pictures is received, and the current picture setting is adjusted to the settings of the selected picture. The process may be repeated.	01-28-2010

Robert Kim, Alpine, NJ US

Patent application number	Description	Published
20120207883	ALKALINE BOOSTER WITH ANTIOXIDANTS - A highly alkaline, ultra-low sodium solution of saturated tripotassium phosphate may be used as an additive to dosages such as concentrated drops, tablets, capsules, bottled water, beverages or other dosage forms. The additive further includes organic potassium, calcium, zinc, magnesium, selenium and 79 trace minerals from ancient sea salt. The trace minerals are taken from the low-sodium technical magnesium chloride marine deposits and chelated with amino acids. The amino acids are from a non-animal source which is suitable for vegetarian and persons who are allergic to animal proteins. The additive, which is considered nutritionally nil in sodium content, can be used as a concentrated aqueous drop or dried and used as an additive for dietary supplement dosage forms including tablets, capsules, bottled water, beverages and others.	08-16-2012

Samuel Kim, Englewood Cliffs, NJ US

Patent application number	Description	Published
20090179987	Motion sickness reduction - A motion sickness reduction device includes an image capture device for capturing an image device environment and an image display device for displaying image related to the captured image. In order to effectively prevent or reduce motion sickness, the right amount of motion must be displayed on the image display device when the vehicle accelerates or turns. Various methods are disclosed for adjusting the image on the display device and/or the angle of the environment subtended to make the motion sickness reduction device effective.	07-16-2009

Sang J. Kim, Morristown, NJ US

Patent application number	Description	Published
20090282100	METHOD FOR SYNDICATING BLOGS AND COMMUNITIES ACROSS THE WEB - A method for syndicating groups from one web site to one or more additional web sites over a distributed network is disclosed. A group is created at the first web site. The group is published to make the group available for syndication. The group is presented as potentially acceptable for syndication at a second web site. A selection is received that the group is acceptable. The group is associated with the second web site in a database. A request is made to the database by the second web site to determine if there is any acceptable group content to be rendered on the second web site. Acceptable content associated with the group is transmitted to the second web site. The acceptable content is rendered at the second web site.	11-12-2009

Seho Kim, Highland Park, NJ US

Patent application number	Description	Published
20090009166	METHOD OF USING G-MATRIX FOURIER TRANSFORMATION NUCLEAR MAGNETIC RESONANCE (GFT NMR) SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS - The present invention presents a new approach to rapidly obtaining precise high-dimensional NMR spectral information, named “GFT NMR spectroscopy”, which is based on the phase sensitive joint sampling of the indirect dimensions spanning a subspace of a conventional NMR experiment. The phase-sensitive joint sampling of several indirect dimensions of a high-dimensional NMR experiment leads to largely reduced minimum measurement times when compared to FT NMR. This allows one to avoid the “sampling limited” data collection regime. Concomitantly, the analysis of the resulting chemical shift multiplets, which are edited by the G-matrix transformation, yields increased precision for the measurement of the chemical shifts. Additionally, methods of conducting specific GFT NMR experiments as well as methods of conducting a combination of GFT NMR experiments for rapidly obtaining precise chemical shift assignment and determining the structure of proteins or other molecules are disclosed.	01-08-2009
20090115414	PHASE-SENSITIVELY DETECTED REDUCED DIMENSIONALITY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY FOR RAPID CHEMICAL SHIFT ASSIGNMENT AND SECONDARY STRUCTURE DETERMINATION OF PROTEINS - The present invention discloses eleven reduced dimensionality (RD) triple resonance nuclear magnetic resonance (NMR) experiments for measuring chemical shift values of certain nuclei in a protein molecule, where the chemical shift values encoded in a peak pair of an NMR spectrum are detected in a phase sensitive manner. The RD 3D	05-07-2009

Seong Heon Kim, Linvington, NJ US

Patent application number	Description	Published
20120010181	COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof.	01-12-2012

Seong Heon Kim, Livington, NJ US

Patent application number	Description	Published
20110065651	HETEROCYCLIC SUBSTITUTED PIPERAZINES WITH CXCR3 ANTAGONIST ACTIVITY - The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1:	03-17-2011
20110288054	COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I) as described herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.	11-24-2011
20110288077	COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES - This invention relates to compounds of the Formula (I)-(IX):, as defined herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-α combinations thereof.	11-24-2011
20120015926	COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.	01-19-2012

Seongkon Kim, Holmdel, NJ US

Patent application number	Description	Published
20100009957	NOVEL INHIBITORS OF BETA-LACTAMASE - A class of 7-oxo-2,6-diazabicyclo-[3.2.0]-heptane-6-sulfonic acid compounds substituted at the two position of the bicyclic ring with a heterocyclylaminocarbonyl group or a carbocyclylaminocarbonyl group are β-lactamase inhibitors. The compounds and their prodrugs and pharmaceutically acceptable salts are useful in the treatment of bacterial infections in combination with β-lactam antibiotics. In particular, the compounds are suitable for use with β-lactam antibiotics (e.g., imipenem and ceftazidime) against micro-organisms resistant to β-lactam antibiotics due to the presence of the β-lactamases.	01-14-2010
20100279983	NOVEL INHIBITORS OF BETA-LACTAMASE - This invention provides novel β-lactamase inhibitors of the aryl- and heteroarylsulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammonium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazidime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.	11-04-2010
20100317625	NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE - This invention provides novel β-lactamase inhibitors of the aryl- and heteroaryl-sulfonamidomethylphosphonate monoester class. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases.	12-16-2010
20110294777	BETA-LACTAMASE INHIBITORS - Substituted bicyclic beta-lactams of Formula I: (I), are β-lactamase inhibitors, wherein a, X, R	12-01-2011

Soo Ii Kim, Flemington, NJ US

Patent application number	Description	Published
20090124586	Aqueous-based pharmaceutical composition - An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of medicament which is effective in treating a bodily condition by virtue of its being present on the mucosal surfaces of the nasal cavity; and (B) a suspending agent in an amount effective to maintain said particles dispersed uniformly in the composition and to impart to the composition the following thixotropic properties: (i) the viscosity of the position in unsheared form is relatively high, with the composition being in gel-like form; (ii) as the composition is subjected to shear (shaken) in preparation for spraying, the viscosity of the composition becomes relatively low and such that the composition in the form of a mist flows readily into the nasal passages for deposit on the mucosal surfaces of the nasal cavity; and (D) in deposited form on the mucosal surfaces, the viscosity of the composition is relatively high and such that it resists being cleared from the mucosal surfaces by the inherent mucocillary forces which are present in the nasal cavity, a method of use of the composition and a method for preparation of the composition, including in preferred form the use of anti-inflammatory steroid, for example, triamcinoline acetonide, and an odorless form of the composition.	05-14-2009

Soo-Il Kim, Flemington, NJ US

Patent application number	Description	Published
20100222314	Aqueous-based Pharmaceutical Composition - An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of medicament which is effective in treating a bodily condition by virtue of its being present on the mucosal surfaces of the nasal cavity; and (B) a suspending agent in an amount effective to maintain said particles dispersed uniformly in the composition and to impart to the composition the following thixotropic properties: (i) the viscosity of the position in unsheared form is relatively high, with the composition being in gel-like form; (ii) as the composition is subjected to shear (shaken) in preparation for spraying, the viscosity of the composition becomes relatively low and such that the composition in the form of a mist flows readily into the nasal passages for deposit on the mucosal surfaces of the nasal cavity; and (D) in deposited form on the mucosal surfaces, the viscosity of the composition is relatively high and such that it resists being cleared from the mucosal surfaces by the inherent mucocillary forces which are present in the nasal cavity, a method of use of the composition and a method for preparation of the composition, including in preferred form the use of anti-inflammatory steroid, for example, triamcinolone acetonide, and an odorless form of the composition.	09-02-2010
20110230455	AQUEOUS-BASED PHARMACEUTICAL COMPOSITION - An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of medicament which is effective in treating a bodily condition by virtue of its being present on the mucosal surfaces of the nasal cavity; and (B) a suspending agent in an amount effective to maintain said particles dispersed uniformly in the composition and to impart to the composition the following thixotropic properties: (i) the viscosity of the position in unsheared form is relatively high, with the composition being in gel-like form; (ii) as the composition is subjected to shear (shaken) in preparation for spraying, the viscosity of the composition becomes relatively low and such that the composition in the form of a mist flows readily into the nasal passages for deposit on the mucosal surfaces of the nasal cavity; and (D) in deposited form on the mucosal surfaces, the viscosity of the composition is relatively high and such that it resists being cleared from the mucosal surfaces by the inherent mucocillary forces which are present in the nasal cavity, a method of use of the composition and a method for preparation of the composition, including in preferred form the use of anti-inflammatory steroid, for example, triamcinoline acetonide, and an odorless form of the composition.	09-22-2011

Soong-Hoon Kim, Titusville, NJ US

Patent application number	Description	Published
20100113458	IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS - The invention provides compounds of Formula (I)	05-06-2010
20100323994	SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS - The invention provides compounds of formula I	12-23-2010

Stanley Sangjin Kim, Watchung, NJ US

Patent application number	Description	Published
20090265137	COMPUTER-BASED METHODS AND SYSTEMS FOR FAILURE ANALYSIS - In accordance with one aspect, the invention provides a method of performing failure analysis on a microelectronic product where the method includes acts of: storing a result of a first test performed on the microelectronic product on a centralized computer; transmitting the result from the centralized computer to a first remote computer for an evaluation of the result by a first evaluator; and transmitting a report form from the centralized computer to the first remote computer for entry of data including analysis supplied by the first evaluator after the evaluation of the result. In accordance with one embodiment, the method also provides acts of: receiving the data at the centralized computer; and storing the data at the centralized computer. In accordance with another embodiment, the method further includes an act of transmitting the result from the centralized computer to a second remote computer for an evaluation of the result by a second evaluator for entry of data including analysis supplied by the second evaluator after the evaluation of the result by the second evaluator.	10-22-2009

Sun Y. Kim, River Vale, NJ US

Patent application number	Description	Published
20080231256	Removable Front Panel Control for Oscilloscope - A test and measurement apparatus is provided including a control panel. The control panel is removable and user-replaceable with an alternate control panel. The control panel can be connected to the test and measurement apparatus or to a generic local computing device to control and interact with the test and measurement apparatus.	09-25-2008
20080278143	Remote Display and Control for Test and Measurement Apparatus - A remote display for a test and measurement apparatus is provided including a control panel. The control panel is removable and user-replaceable with an alternate control panel. The control panel can be connected to the remote display device to control and interact with the test and measurement apparatus, and to control the display of information on the remote display device.	11-13-2008

Taek Kim, Washington Township, NJ US

Patent application number	Description	Published
20120152958	WASTE STORAGE DEVICE - The present invention discloses an automated sealing waste disposal apparatus using tubular material.	06-21-2012

Taesoon Kim, Fort Lee, NJ US

Patent application number	Description	Published
20090202055	SYSTEM AND METHOD FOR PROVIDING PREPAID TELECOMMUNICATION SERVICES - The present invention relates to a system and method for providing prepaid telecommunication services. More particularly, prepaid telephone calls can be made by users without entering any access code, if such calls are made from telephone numbers previously registered in the telecommunication system in connection with valid access codes. Prepaid telephone calls can also be made from non-registered telephone numbers after providing the telecommunication system with a valid access code.	08-13-2009

Wonho Kim, Princeton, NJ US

Patent application number	Description	Published
20110261688	Priority Queue Level Optimization for a Network Flow - Optimizing priority queue levels for a flow in a network includes determining a path for the flow, determining an optimized priority queue level of the flow at each of a plurality of switches based on a Quality of Service (QoS) requirement of the flow and priority queue levels of one or more existing flows in the network. Information of the optimized priority queue level of the flow is sent to at each of the switches.	10-27-2011
20120155264	Dynamic Balancing Priority Queue Assignments for Quality-of-Service Network Flows - A priority queue assignment technique for quality-of-service (“QoS”) network flows in a network is provided. A network path is determined for an incoming flow including a plurality of network switches associated, with a plurality of priority queue levels. A priority queue level is determined for the incoming flow for at least one of the plurality of network switches in the network path based on priority queue levels of existing flows. The priority queue level of the incoming flow is adjusted, to dynamically balance flows over the plurality of priority queue levels for at least one of the plurality of network switches in the network path based on quality-of-service (“QoS”) requirements associated with the incoming flow.	06-21-2012

Wookyu Kim, Bridgewater, NJ US

Patent application number	Description	Published
20080196626	SILICONE COATING COMPOSITION - The present invention relates to a composition comprising:	08-21-2008
20080292995	Antireflective Coating Composition Comprising Fused Aromatic Rings - The present invention relates to an organic spin coatable antireflective coating composition comprising a polymer comprising at least one unit with 3 or more fused aromatic rings in the backbone of the polymer and at least one unit with an aliphatic moeity in the backbone of the polymer. The invention further relates to a process for imaging the present composition.	11-27-2008
20100092895	SILICON-BASED ANTIREFLECTIVE COATING COMPOSITIONS - A polymer comprising a siloxane polymer having at least one Si—OH group and at least one Si—OR group, where R is condensation stabilizing group optionally having a reactive functional group, wherein the siloxane polymer, when placed into a solvent, has a weight average molecular weight increase of less than or equal to 50% after aging for one week at 40° C. as measured by GPC is provided.	04-15-2010

Yong Jung Kim, Fort Lee, NJ US

Patent application number	Description	Published
20090149862	Guide pin for pedicle screw placement and method for use of such guide pin in spinal fusion surgeries - A radiopaque guide pin that is insertable into a pedicle of a vertebra to be used as a guide to determine the proper and safe entry point and angular trajectory for a pedicle screw placed in a pedicle, has a distal part and terminal tip for initial entry of the guide pin, an opposite proximal part that serves as a handle, and a central part that includes a first radiopaque marker spaced proximally from the tip and a stop element spaced proximally from the first marker, the stop element having greater diameter than the distal and central parts of the guide pin and adapted to be stopped by the lamina surface from further advancement into the pedicle. The invention further includes a method for pedicle screw placement using the new pedicle screw guide pin.	06-11-2009

Young Gin Kim, Edison, NJ US

Patent application number	Description	Published
20100158780	Small Engine Palladium Catalyst Article and Method of Making - Catalyst articles comprising substantially only a palladium precious metal component and related methods of preparation and use are disclosed. Disclosed is a catalyst article comprising a first layer formed on a carrier substrate, wherein the first layer comprises a refractory metal oxide and has a surface that is substantially uniform; and a second layer formed on the first layer, wherein the second layer comprises i) an oxygen storage component that is about 50-90% by weight of the second layer and ii) a palladium component in an amount of about 10-150 g/ft	06-24-2010